M2I Lifesciences
Founded 2012 · 127 employees on LinkedIn · 1 known investors
M2i is a French industrial group specializing in complex molecules and pheromone-based biocontrol products used to protect plants and crops as an alternative to conventional chemical pesticides. It also develops and manufactures active ingredients and intermediates for organic chemistry and life sciences, serving conventional and organic agriculture.
Also known as M2i · M2i Group · M2i LifeSciences
Investors · 1
Company profile
researched Aug 2026M2i Lifesciences (M2i Group) is a French industrial group active in complex-molecule chemistry and in pheromone-based biological plant and crop protection, positioned as a substitute for conventional chemical pesticides. Its biocontrol products reproduce, through a biomimetic process, the natural pheromones emitted by insects in order to disrupt or repel crop pests, and are designed for use in both conventional (integrated) and organic farming, offering residue-free protection.
The group is entirely French-based, operating four sites in France and covering the whole value chain: R&D laboratories, production of active ingredients and formulation, field trials and regulatory registration. A second activity line, chemistry and life sciences, uses the group's organic-chemistry expertise and industrial infrastructure to develop and produce active ingredients and intermediates. Reported figures include 60 crops protected, solutions used in 80 countries, 40 patent families, 45 awards, an average of 20,000 tonnes of pesticides avoided per year, and 180 employees.
Business model
M2i controls the full value chain in-house, from R&D laboratories through active-ingredient synthesis and formulation to field trials and regulatory registrations, and produces and distributes finished biocontrol products. Alongside its own biocontrol range, it develops and manufactures active ingredients and intermediates using its organic-chemistry and industrial capabilities.
Traction
Company-reported indicators: 180 collaborators, 60 crops protected, use in 80 countries, 40 patent families, 45 awards and an average of 20,000 tonnes of pesticides avoided per year. In December 2022 the group reported 200 employees across four French sites.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Described as a French industrial group and European leader in pheromone-based biological crop protection; a 2022 regional press article characterised it as a prospective global leader in biocontrol.
The company states it is the European leader in pheromone-based biological protection of plants and crops, relying on a biomimetic reproduction of insect pheromones, integrated mastery of the value chain from laboratory to registration, 40 patent families and fully French industrial infrastructure.
Technology
Biomimetic synthesis of insect pheromones — identical reproduction of the natural odours emitted by insects — formulated into biocontrol products that repel or control crop pests without leaving residues, supported by organic-chemistry expertise, R&D laboratories and industrial production and formulation facilities.
Go-to-market
Growers in conventional/integrated and organic agriculture across a wide range of crops, plus customers for active ingredients and organic-chemistry intermediates in chemistry and life sciences.
Geography
Headquartered and manufacturing in France with four sites, including a plant in the Lacq basin in Béarn (Nouvelle-Aquitaine); the group describes a worldwide presence with its solutions used in 80 countries.
History
In December 2022 the group inaugurated a new 2,700 m2 plant in the Lacq industrial basin in Béarn for the production of pheromone-based biological insecticides, adding capacity to a local site that already employed around thirty people; the investment was supported by Chemparc, the Communauté de communes Lacq-Orthez and the Nouvelle-Aquitaine region. At that time the company reported around 200 employees across four French sites, and its site later reports 180 staff.
Compiled by commissioned research from 3 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsM2i inaugurated a new 2,700 m2 factory in the Lacq industrial basin dedicated to producing pheromone-based biological insecticides, reinforcing a site where around thirty employees were already based. The project was supported by Chemparc, the Communauté de communes Lacq-Orthez and the Nouvelle-Aquitaine region.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 3
primary sources listed
- M2I Lifesciencesm2i-lifesciences.com · web
3 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does M2I Lifesciences do?
- French industrial group producing pheromone-based biocontrol products and complex molecules as alternatives to chemical pesticides.
- Who are M2I Lifesciences's investors?
- M2I Lifesciences's investors include Bootstrap Europe.